6785Alar Pharmaceuticals6785 info
$5.67info-0.55%24h
Global rank14212
Market cap$323.47M
Change 7d-6.92%
YTD Performance-13.57%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Alar Pharmaceuticals (6785) Stock Overview

    Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. It is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid use disorder; ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; ALA-4000 which is in pre-clinical stage for treatment of Parkinson's disease; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.

    6785 Stock Information

    Symbol
    6785
    Address
    No. 32, Keya RoadTaichung, 407Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://www.alarpharm.com
    Country
    🇹🇼 Taiwan
    Phone Number
    886 4 2463 7115

    Alar Pharmaceuticals (6785) Price Chart

    -
    Value:-

    Alar Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $5.67
    N/A
    Market Cap
    $323.47M
    N/A
    Shares Outstanding
    57.00M
    N/A
    Employees
    21.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org